Arrowhead Prescription drugs Presents New Pivotal Section 3 Information at ESC 2024 from PALISADE Examine of Plozasiran in Sufferers with Familial Chylomicronemia Syndrome
- Plozasiran lowered triglycerides by 80% from baseline and lowered the chance…
ARS Prescribed drugs CFO sells $200,000 value of shares By Investing.com
ARS Prescribed drugs, Inc. (NASDAQ:SPRY) reported a big transaction by Chief Monetary…
Acadia Prescribed drugs CEO sells shares value over $485k By Investing.com
Acadia Prescribed drugs Inc. (NASDAQ:ACAD) CEO Stephen Davis just lately engaged in…
Madrigal Prescribed drugs senior VP sells $570,000 in inventory By Investing.com
WEST CONSHOHOCKEN, PA – Current filings with the Securities and Trade Fee…
Vanda Prescribed drugs weighs buyout supply from Cycle Grou By Investing.com
WASHINGTON - Vanda (NASDAQ:) Prescribed drugs Inc. (NASDAQ:VNDA), a worldwide biopharmaceutical firm,…
Mirum Prescribed drugs’ LIVMARLI Knowledge Showcased at ESPGHAN Annual Assembly By Investing.com
- Seven abstracts highlighting ALGS and PFIC knowledge, together with three oral…
Ars Prescription drugs CEO sells over $934k in firm inventory By Investing.com
ARS Prescription drugs, Inc. (NASDAQ:SPRY) has reported that its President and CEO,…
